Related Experiment Video
Updated: Aug 27, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
The role of the Bcl-2 protein family in cancer
Leigh Coultas1, Andreas Strasser
1Molecular Genetics of Cancer Division, The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Vic. 3050, Australia.
Abstract:
Seminal studies on the proto-oncogene bcl-2 have first demonstrated that mutations that inhibit programmed cell death (apoptosis) can promote lymphomagenesis and influence the sensitivity of tumour cells to chemotherapy or radiotherapy. It is now widely believed that neoplastic transformation of many, perhaps even all, cell types requires mutational changes that interfere with the cell death programme. In this review, we describe current knowledge of the molecular control of cell death and discuss the role of pro- and anti-apoptotic members of the Bcl-2 protein family in tumourigenesis and anti-cancer therapy.
Insights
Mutations inhibiting programmed cell death (apoptosis) drive cancer. The Bcl-2 protein family plays a key role in cancer development and treatment, influencing cell death pathways.
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Programmed cell death (apoptosis) is crucial for preventing uncontrolled cell proliferation.
- Mutations disrupting apoptosis are implicated in various cancers, including lymphomas.
- The Bcl-2 family of proteins regulates apoptosis.
Purpose of the Study:
- To review the molecular mechanisms controlling programmed cell death.
- To discuss the role of Bcl-2 family proteins in cancer development.
- To explore the implications of Bcl-2 proteins in anti-cancer therapies.
Main Methods:
- Literature review of seminal studies and current research on Bcl-2 and apoptosis.
- Analysis of molecular pathways regulating cell death.
- Synthesis of findings on the role of Bcl-2 family members in tumorigenesis.
Main Results:
- Inhibiting apoptosis through mutations, particularly involving Bcl-2, promotes cancer.
- The balance of pro-apoptotic and anti-apoptotic Bcl-2 proteins is critical in cancer.
- Bcl-2 family proteins affect cancer cell sensitivity to chemotherapy and radiotherapy.
Conclusions:
- Interference with programmed cell death is a hallmark of neoplastic transformation.
- Targeting Bcl-2 family proteins offers potential therapeutic strategies for cancer.
- Understanding Bcl-2's role is vital for advancing cancer treatment and prevention.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Intrinsic Apoptotic Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

